[{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.117.1.7.1.134","meta":{"versionId":"51","lastUpdated":"2022-02-12T01:02:18.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-02-12"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.134","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.117.1.7.1.134"}],"version":"20220212","name":"Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment","title":"Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment","status":"active","experimental":false,"date":"2022-02-12T01:02:18-05:00","publisher":"TJC EH Steward","expansion":{"identifier":"urn:uuid:e11b674a-9059-4b69-94b6-8a1ce1e5c1f7","timestamp":"2023-12-20T21:33:22-05:00","total":6,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"1364435","display":"apixaban 2.5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"1364445","display":"apixaban 5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"1599543","display":"edoxaban 15 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"1599551","display":"edoxaban 30 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"1599555","display":"edoxaban 60 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"12042023","code":"1992427","display":"{74 (apixaban 5 MG Oral Tablet) } Pack"}]}}]
